However, the majority of these patients could have GRPR expression (>75% in primary prostate cancer and >85% in lymph node metastases), as GRPR expression is associated with small lesions in low-grade prostate cancer [9,10,28]. The gene discussed is GRPR; the disease is prostate carcinoma.